SCHEMBL4311903

SCHEMBL4311903

CC(C)(C)OC(=O)N1CCC(COc2cc3c(=O)[nH]c(-c4cccc(Cl)c4)cn3c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AVPR1B P47901 3/20 0.48
CHEK2 O96017 1/20 0.44
STS P08842 1/20 0.44
GPR119 Q8TDV5 5/20 0.43
SLC2A1 P11166 1/20 0.41
TP53 P04637 1/20 0.41
POLB P06746 1/20 0.41
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TNKS O95271 1/20 0.39
PARP1 P09874 1/20 0.39
TNKS2 Q9H2K2 1/20 0.39
CSF1R P07333 1/20 0.39
NOTCH1 P46531 1/20 0.39
HPGDS O60760 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4310057 0.93 AVPR1B (0.49) AVPR1BCHEK2STSGPR119TP53
SCHEMBL4302952 0.88 AVPR1B (0.46) AVPR1BCHEK2STSGPR119TP53
SCHEMBL4310061 0.82 AVPR1B (0.54) AVPR1B
SCHEMBL2351366 0.78 GPR119 (0.54) CHEK2STSGPR119SLC2A1TP53
SCHEMBL3962648 0.75 STS (0.48) STSGPR119TP53POLBSMN1; SMN2
SCHEMBL26668458 0.74 SLC2A1 (0.59) CHEK2GPR119SLC2A1CSF1R
SCHEMBL31071546 0.74 STS (0.53) CHEK2STSGPR119SLC2A1TP53
SCHEMBL3256200 0.73 GPR119 (0.57) CHEK2STSGPR119
SCHEMBL8018250 0.73 TNKS (0.46) TNKSPARP1TNKS2CSF1R
SCHEMBL13097087 0.71 SLC2A1 (0.57) CHEK2GPR119SLC2A1CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009130231-A1 PYRROLO [1, 2-A] PYRAZINE DERIVATIVES AS VASOPRESSIN VIB RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2009-10-29 WO disclosed
WO-2009130231-A1 PYRROLO [1, 2-A] PYRAZINE DERIVATIVES AS VASOPRESSIN VIB RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2009-10-29 WO disclosed